Representative Matters

Mergers & Acquisitions Transactions

Mr. Weiss provided representation to:

  • a private equity-backed national wound care management services company in its acquisition of a regional wound care management services company
  • a venture-backed health care staffing company in its sale to a private equity-backed purchaser
  • a publicly-held software and services provider in its merger with and into another software and services provider
  • a New York-based accounting firm in connection with its merger with a multinational accounting firm
  • a national for-profit hospital system in connection with its acquisition of a Rhode Island-based multi-hospital system
  • a privately held pharmaceutical company in connection with its sale of a product line to a specialty pharmaceutical company
  • a health care accounts receivables management company in its sale to a private equity-backed strategic purchaser
  • an NYSE-listed pharmaceutical company in its sale of certain of its Egyptian plant and operations to another major pharmaceutical company
  • an NYSE-listed medical device manufacturer in its sale to a Fortune 25 health care company
  • a multi-hospital nonprofit system in connection with its acquisition of another nonprofit hospital
  • a community hospital in connection with its sale to a large multi-hospital system
  • a private clinical trial materials company in its sale to a private equity-backed strategic purchaser
  • a receivables and loan collections company in connection with an investment by a financial sponsor
  • an apparel company in its acquisition of a retail clothing chain with stores throughout the United States
  • an Irish private equity sponsor in its purchase of an international provider of temporary corporate housing from a NYSE-listed seller
  • an Australian, publicly held biotechnology company in its sale of assets related to two product lines to a U.S.-based purchaser
  • a Spanish-based renewable energy company in its purchase of an equity stake in a U.S.-based company
  • a private market research firm in its sale to a German-based strategic purchaser
  • an education and training business in its sale to a Nasdaq National Market-listed strategic purchaser
  • a public software and services provider in its purchase of a software development and IT consulting firm and its purchase of a software development company
  • a private equity sponsor in its purchase of a Georgia-based manufacturing and processing company
  • a private equity-backed metal-part fabricator in its purchase of a Wisconsin-based metal fabricator
  • an NYC-based hospital, home health care program and skilled nursing facility in a Section 363 sale of its assets in bankruptcy

Public Company/SEC

Mr. Weiss represented the following entities:

  • an NYSE Amex-listed health and wellness and risk assessment services company
  • a Nasdaq Global Market-listed medical device manufacturer
  • an NYSE Amex-listed software and services provider
  • an NYSE-listed medical device manufacturer
  • an AMEX-listed mortgage REIT

Capital Markets/Securities Transactions

Mr. Weiss provided representation to:

  • the lead underwriter in the $55.2 million follow-on common stock offering of Somanetics Corporation, a medical device company that develops and manufactures non-invasive patient oximetric monitoring systems
  • an NYSE-listed medical device manufacturer in its comprehensive $550 million recapitalization, which involved simultaneous common stock and high-yield debt offerings, establishment of a new bank credit facility, tender offers for three outstanding series of high-yield debt, and a merger
  • the lead underwriter in the $85 million follow-on common stock offering of Intuitive Surgical, Inc., a medical device company that manufactures robotic surgical systems
  • a global offshore software development company in its $50 million private placement of preferred stock
  • a mortgage REIT in its $34.5 million follow-on offering of common stock
  • a mortgage REIT in its $20 million private placement of trust preferred securities
  • an investment bank, as lead underwriter, in connection with a BDC issuer, as candidate for an initial public offering
  • a private equity/VC investor group in connection with the acquisition of preferred stock in a marketing program provider